833775

Janssen Pharmaceuticals Inc. — FEI 2211100

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 21, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Raritan, NJ (United States)

Additional Details

Risk Evaluation and Mitigation Strategies (REMS)